Children ages 6-17 with Tourette’s Syndrome

IRB/UVA Tracking #
Principal Investigator
Vishal Madaan
Kristina Muniz
Contact Phone
Official Trial Title
A Multicenter, Placebo-Controlled, Double-Blind, Randomized, Parallel-Group, Phase 2b Study to Evaluate the Efficacy and Safety of Ecopipam Tablets in Children and Adolescent Subjects with Tourette’s Syndrome
Study Description

The department of psychiatry and neurobehavioral sciences, division child and family psychiatry is seeking children ages 6-17 with Tourette ’s syndrome for a research study. The purpose of the study is evaluate the safety and efficacy of the study drug (ecopipam).

Your child may be eligible for this study if they are 6-17 years old and have been diagnosed with Tourette’s syndrome.

This study involves blood draws, ECGs, physical exams, psychiatric assessments, and taking the study medication/placebo daily. There will be approximately 11 visits to the study center over 4-5 months.

The study drug and all study-related medical tests and procedures are provided at no cost to qualified participants.


$75.00 per completed study visit